Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-03

FDA Approved: MYCOPHENOLIC ACID — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Upsher-Smith's original application for generic mycophenolic acid, an immunosuppressant used to prevent organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolic acid (mycophenolic acid)

Snippet

ORIG AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)